Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

intestinal neuroendocrine tumor G1 - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

intestinal neuroendocrine tumor G1

MONDO:0021533

Also known as:carcinoid tumor of intestinecarcinoid tumor of the intestinecarcinoid tumour of intestine

Find Clinical TrialsTrials

Overview

A well differentiated, low grade neuroendocrine tumor (carcinoid tumor) that arises from the small or large intestine. The mitotic count is less than 2 per 10 HPF and/or the Ki67 index is equal to or less than 2 percent.

GeneticsAutosomal dominant

Clinical Trials2 registered

ResearchLimited published research (5 articles)

Clinical Presentation

Features include: Intestinal carcinoid.

Organ System	Phenotype Count	Example Features
Digestive system	1	Intestinal carcinoid

Explore clinical features

Diagnosis

Biomarker and diagnostic research for intestinal neuroendocrine tumor G1 has been reported in the published literature.

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

2 clinical trials registered. Interventions under study include drug therapy. Pipeline includes 1 PHASE3, 1 PHASE2. Research is primarily industry-sponsored.

5 publications have been identified in PubMed for intestinal neuroendocrine tumor G1. Research spans Case Report / Case Series (60%) and Diagnostic / Biomarker (40%).

Recent Publications

Shinkubo N (2026). [PMID: 42098036](https://pubmed.ncbi.nlm.nih.gov/42098036/). *Gan To Kagaku Ryoho*. [Case Report / Case Series]
Sarioglu AG (2024). [PMID: 37945469](https://pubmed.ncbi.nlm.nih.gov/37945469/). *American journal of surgery*. [Diagnostic / Biomarker]
Soroa M (2024). [PMID: 38703080](https://pubmed.ncbi.nlm.nih.gov/38703080/). *European heart journal. Cardiovascular Imaging*. [Case Report / Case Series]
Jacques V (2024). [PMID: 38948517](https://pubmed.ncbi.nlm.nih.gov/38948517/). *Frontiers in endocrinology*. [Diagnostic / Biomarker]
Rojas Sánchez Á (2024). [PMID: 38838720](https://pubmed.ncbi.nlm.nih.gov/38838720/). *Endoscopy*. [Case Report / Case Series]

Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 3:06 AM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

External Resources

OMIM

Online Mendelian Inheritance in Man

OMIM:114900

Questions for Your Care Team

→Are any of the 2 active clinical trials a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

intestinal neuroendocrine tumor G1

Overview

Clinical Presentation

Explore clinical features

Diagnosis

Research Landscape

Recent Publications

Medical References

External Resources

OMIM

Related Diseases

Questions for Your Care Team

Questions for Your Care Team